HealthcareFTC finds PBMs excessively marked up prices on specialty drugsJan. 14, 2025 12:52 PM ETCVS Health Corporation (CVS) StockUNH, CIBy: Val Brickates Kennedy, SA News Editor10 CommentsPlay(2min)JHVEPhotoA new report issued by the Federal Trade Commission has found that prescription benefit manager units owned by CVS Health (NYSE:CVS), Cigna (CI) and UnitedHealth Group (UNH) significantly marked up prices for many specialty genericRecommended For YouAbout CVS StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield Rev Growth (YoY)Short InterestPrev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgCVS--CVS Health CorporationTrending AnalysisTrending News
